Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome [Medical Sciences]

Activating mutations in the KIT or PDGFRA receptor tyrosine kinases are hallmarks of gastrointestinal stromal tumor (GIST). The biological underpinnings of recurrence following resection or disease progression beyond kinase mutation are poorly understood. Utilizing chromatin immunoprecipitation with sequencing of tumor samples and cell lines, we describe the enhancer landscape of...

https://ift.tt/2JOzRnu